Skip to main content

Table 3 Treatment compliance

From: Use, tolerability and compliance of spironolactone in the treatment of heart failure

 

Compliance

 

50%

80%

ACE

66.4%

56.1%

ARB

68.1%

57.0%

β-blockers

71.1%

59.7%

Spironolactone

58.4%*

45.6%*

  1. * Spironolactone versus ACE, ARB and β-blockers: p < 0.001 (Pearson's chi square test)